A Michigan registered nurse (RN) was sentenced to two years in federal prison for tampering with a consumer product, specifically the Schedule II controlled substance fentanyl. The announcement was made by United States Attorney Jerome F. Gorgon Jr. on November 25, 2025.
The 54-year-old RN from Grosse Pointe Park, Michigan, worked in a hospital emergency room until August 2022. In his guilty plea, the defendant admitted that he tampered with vials containing fentanyl, a powerful narcotic pain reliever, knowing they were intended for administration to patients in the hospital’s emergency department.
According to the plea, the RN removed fentanyl from the vials, replaced it with another liquid, and returned the tampered vials to the locked drug storage system. He did so with reckless disregard for the danger this posed to patients. The defendant also admitted to stealing fentanyl vials for personal use as part of a pattern of thefts from May to August 2022. He was immediately removed from his position when the hospital discovered the tampering and thefts.
United States Attorney Gorgon stated, “When [the RN] placed tampered vials back into the hospital’s medical supply, he exposed patients in desperate need of pain relief to continued suffering. This is a reprehensible crime. No medical professional should torture a patient. I credit the hospital and the FDA investigators for their work in exposing this crime.”
Compliance Perspective
Issue
Failure to prevent the diversion of prescribed controlled medications by staff can constitute abuse, neglect, misappropriation, and fraud, violating both state and federal regulations. Staff involved in diversion may develop methods to conceal their actions, increasing the difficulty of early detection. Facilities should implement a proactive diversion-prevention program that identifies medications most vulnerable to diversion, recognizes indicators that diversion has occurred, and identifies signs of staff impairment.
Discussion Points
- Regularly review your facility’s policies and procedures related to preventing, identifying, and responding to drug diversion. Ensure these policies comply with state and federal requirements and reflect current best practices, including emerging methods of diversion. Facilities may also benefit from periodic policy evaluations conducted with the support of an external consultant to help identify regulatory gaps or risks that may otherwise be overlooked.
- Ensure appropriate staff receive training on how to prevent, identify, and respond to suspected drug diversion. Education should emphasize the impact of diversion on residents as a form of abuse and neglect, the responsibility to report concerns promptly, and the legal and professional consequences of diversion. Med-Net Academy offers three training programs in its Substance Use category, which can help reinforce these competencies and support facility compliance.
- Implement periodic audits to verify that controlled substances are properly accounted for each shift and that documentation is complete, consistent, and accurate. Audits should be thorough and include review of medication records for discrepancies or unusual patterns. Collaboration with a consultant pharmacist or other qualified external reviewer can strengthen this process by providing an additional layer of oversight and helping facilities detect potential issues before they escalate.
*This news alert has been prepared by Med-Net Concepts, Inc. for informational purposes only and is not intended to provide legal advice.*